NEW YORK (GenomeWeb) – Quest Diagnostics announced this week that its board of directors has declared a quarterly cash dividend of $.45 per share, payable on April 19 to shareholders of record on April 5.

Luminex said this week that its board of directors has authorized the initiation of a quarterly cash dividend to its shareholders for the first time in the company's history. The dividend of $.06 per share will be payable on April 14 to shareholders of record as of the close of business on March 24. This represents a planned annual dividend of $.24 per share. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.

Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.

In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.

Iceland has nearly eliminated Down syndrome from its population, CBS News reports.